Medicine and Dentistry
Neoplasm
100%
Clinical Study
91%
Oncology
91%
Prodrug
91%
Homologous Recombination
91%
Hypoxia
91%
Radiosensitivity
91%
DNA Damage
61%
Single Drug Dose
61%
Radiation Therapy
61%
Clinical Trial
30%
Antineoplastic Activity
30%
Tumor Cell
30%
Recurrent Disease
30%
Oxidoreductase
30%
Malignant Neoplasm
30%
Pimonidazole
30%
Carboplatin
30%
Xenograft
30%
Tumor Hypoxia
30%
Monotherapy
30%
Tumor Model
30%
BRCA1
25%
Cancer Treatment
16%
Patient Selection
8%
Double Stranded DNA
8%
Biological Marker
8%
Clinical Assessment
8%
Germ Cell
8%
INIS
tumors
100%
gene recombination
91%
precision
91%
mutations
91%
probability
91%
hypoxia
91%
radioresistance
91%
control
91%
patients
47%
vehicles
30%
dna damages
30%
radiotherapy
30%
fractionated irradiation
30%
stratification
23%
detection
16%
therapy
16%
injection
15%
radiation doses
15%
tumor cells
15%
schedules
15%
mice
15%
licenses
15%
radiations
15%
cancer
15%
in vivo
15%
volume
15%
animals
15%
clinical trials
15%
doses
15%
comparative evaluations
15%
Keyphrases
Hypoxia-activated Prodrug
91%
Local Tumor Control
91%
Tumor Control Probability
91%
Radioresistance
91%
Scar
91%
Precision Oncology
91%
CP-506
91%
Homologous Recombination Deficiency
91%
FaDu
38%
BRCA1, BRCA2
25%
Tumor
15%
Patient Stratification
15%
DNA Damage
15%
Mutational Signatures
8%
Genomic Signature
8%
DNA Double-strand Breaks
8%
Detection Accuracy
8%
Patient Outcomes
8%
Mutational Status
8%
Germ Cells
8%
Targeted Cancer Therapy
8%
Patient Selection
8%
Clinical Assessment
8%
Anticancer Therapy
8%
Enhanced Sensitivity
8%
Hypoxia
7%
Hypoxic Tumors
7%
Monotherapy
7%
Tumor Model
7%
Hypoxic Volume
7%
